These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 19653472

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Monoclonal antibodies targeting VEGF in ophthalmology: the case of exudative age-related macular degeneration].
    Leveziel N, Soubrane G, Souied EH.
    Med Sci (Paris); 2009 Dec; 25(12):1105-7. PubMed ID: 20035686
    [Abstract] [Full Text] [Related]

  • 4. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.
    Retina; 2007 Dec; 27(4):432-8. PubMed ID: 17420694
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H, Chu KW, Campochiaro P, Gehlbach PL, Haller JA, Handa JT, Nguyen QD, Sung JU.
    Hum Gene Ther; 2001 Nov 01; 12(16):2029-32. PubMed ID: 11727737
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.
    Spaide RF, Laud K, Fine HF, Klancnik JM, Meyerle CB, Yannuzzi LA, Sorenson J, Slakter J, Fisher YL, Cooney MJ.
    Retina; 2006 Apr 01; 26(4):383-90. PubMed ID: 16603955
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H, Ventura AA, Chung JY, Sharma S, Kaiser PK.
    Ophthalmology; 2009 Sep 01; 116(9):1740-7. PubMed ID: 19643484
    [Abstract] [Full Text] [Related]

  • 14. Age-Related Macular Degeneration.
    Mehta S.
    Prim Care; 2015 Sep 01; 42(3):377-91. PubMed ID: 26319344
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration.
    Ladas ID, Chatziralli IP, Kotsolis AI, Douvali M, Georgalas I, Theodossiadis PG, Rouvas AA.
    Ophthalmologica; 2012 Sep 01; 228(2):93-101. PubMed ID: 22571933
    [Abstract] [Full Text] [Related]

  • 17. [Antiangiogenic therapy for choroidal neovascularization induced by age-related macular degeneration (preliminary communication)].
    Avetisov SE, Mamikoian VR, Surguch BK, Sdobnikova SV.
    Vestn Oftalmol; 2009 Sep 01; 125(6):3-8. PubMed ID: 20143531
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment according to "evidence-based medicine" of aged-related exudative age-related macular degeneration (laser photocoagulation and photodynamic therapy)].
    Donati G.
    Klin Monbl Augenheilkd; 2001 May 01; 218(5):313-5. PubMed ID: 11417324
    [Abstract] [Full Text] [Related]

  • 20. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
    Kaiser PK, Blodi BA, Shapiro H, Acharya NR, MARINA Study Group.
    Ophthalmology; 2007 Oct 01; 114(10):1868-75. PubMed ID: 17628683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.